XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

Revenue (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Disclosure [Abstract] |
Summary of licensing revenue |
|  | 2025 A$’000 |  |  | 2024 A$’000 |  |  | 2023 A$’000 |
Licensing revenue |  |  | — |  |  |  | 2,301 |  |  |  | — |
Sale of Paxalisib |  |  | 42 |  |  |  | 7 |  |  |  | — |
|  |  | 42 |  |  |  | 2,308 |  |  |  | — |
Summary of disaggregation of revenue from contracts with customers |
|  | 2025 A$’000 |  |  | 2024 A$’000 |  |  | 2023 A$’000 |
Geographical regions |  |  |  |  |  |  |  |  |  |  |  |
South Korea |  |  | — |  |  |  | 2,308 |  |  |  | — |
Israel |  |  | 42 |  |  |  | — |  |  |  | — |
|  |  | 42 |  |  |  | 2,308 |  |  |  | — |
Timing of revenue recognition |  |  |  |  |  |  |  |  |  |  |  |
Licensing revenue recognised at a point in time |  |  | — |  |  |  | 2,301 |  |  |  | — |
Sale of Paxalisib at a point in time |  |  | 42 |  |  |  | 7 |  |  |  | — |
|  |  | 42 |  |  |  | 2,308 |  |  |  | — |

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Paragraph 114 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the entity's products and services. [Refer: Products and services [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2025-01-01 -Paragraph 32 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfProductsAndServicesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | kzia_DisclosureAbstract
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration